BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 7, 2025

  May 8, 2025

   · 

  1 min read
• Press Releases

  Ultragenyx to Participate at Bank of America’s 2025 Healthcare Conference

  May 8, 2025

   · 

  1 min read
• Press Releases

  Pasithea Therapeutics Announces Closing of $5 Million Public Offering

  May 8, 2025

   · 

  5 min read
• Press Releases

  Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 ENSURE Study at EASL Congress 2025, Suggesting BRII-179’s Role in Advancing Higher HBsAg Loss

  May 8, 2025

   · 

  8 min read
• Press Releases

  argenx Reports First Quarter 2025 Financial Results and Provides Business Update

  May 8, 2025

   · 

  16 min read
• Press Releases

  Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General Business Update

  May 8, 2025

   · 

  3 min read
• Press Releases

  Genespire announces oral presentation at the ASGCT Annual Meeting detailing preclinical insights into dosing for first-in-human in vivo liver-directed ISLV gene therapy for MMA

  May 8, 2025

   · 

  1 min read
• Press Releases

  Zealand Pharma Announces Financial Results for the First Three Months of 2025

  May 8, 2025

   · 

  11 min read
• Press Releases

  Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress

  May 8, 2025

   · 

  10 min read
• Press Releases

  NewBiologix Licenses Xcell-Eng-HEK293 Cell Line to ReciBioPharm for Development and Manufacture of Adeno-Associated Virus (AAV) Therapeutics

  May 8, 2025

   · 

  5 min read